Immune Response to SA14-14-2 Live Attenuated Japanese Encephalitis Vaccine
暂无分享,去创建一个
[1] E. Hindle. Yellow fever vaccine , 1928, Reactions Weekly.
[2] S. Halstead,et al. Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules. , 1998, The Journal of infectious diseases.
[3] S. Halstead,et al. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects. , 1997, The Journal of infectious diseases.
[4] T. Monath,et al. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. , 1997, Vaccine.
[5] T. Rønne,et al. Allergic mucocutaneous reactions to Japanese encephalitis vaccine. , 1997, Vaccine.
[6] Diana M. Novak,et al. Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] P. Arlien‐Søborg,et al. Neurological complications and Japanese encephalitis vaccination , 1996, The Lancet.
[8] S. Halstead,et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study , 1996, The Lancet.
[9] N. Karabatsos,et al. Japanese encephalitis vaccine: persistence of antibody up to 3 years after a three-dose primary series. , 1995, The Journal of infectious diseases.
[10] A. Barrett,et al. Nucleotide and deduced amino acid sequence of the structural protein genes of Japanese encephalitis viruses from different geographical locations. , 1995, The Journal of general virology.
[11] N. Begg,et al. Systemic allergic reactions to Japanese encephalitis vaccines. , 1994, Vaccine.
[12] Tennessee.,et al. Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[13] Japanese encephalitis vaccine gets the nod , 1992 .
[14] T. Ruff,et al. Adverse reactions to Japanese encephalitis vaccine , 1991, The Lancet.
[15] K. Ungchusak,et al. A field trial of inactivated mouse brain japanese encephalitis vaccines produced in thailand , 1991 .
[16] C. B. Cropp,et al. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. , 1990, The Journal of infectious diseases.
[17] A. Nisalak,et al. Protection against Japanese encephalitis by inactivated vaccines. , 1988, The New England journal of medicine.
[18] Y. Xin,et al. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. , 1988, The American journal of tropical medicine and hygiene.
[19] K. Fukai,et al. Neutralizing antibody responses to Japanese encephalitis vaccine in children. , 1983, Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology.
[20] C. Kuo,et al. Japanese encephalitis surveillance in China (Province of Taiwan) during 1968-1971. I. Geographical and seasonal features of case outbreaks. , 1975, Japanese journal of medical science & biology.
[21] C. Kuo,et al. Japanese encephalitis surveillance in China (Province of Taiwan) during 1968-1971. II. Age-secific incidence in connection with Japanese encephalitis vaccination program. , 1975, Japanese journal of medical science & biology.
[22] A. Nisalak,et al. A plaque reduction test for dengue virus neutralizing antibodies. , 1967, Journal of immunology.